Benefits and risks of drugs in secondary prevention of ischaemic heart disease--a summary.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001581:Benzothiadiazines; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy* / Q000517:prevention & control; D004232:Diuretics; D005260:Female; D006801:Humans; D007256:Information Systems; D008297:Male; D012306:Risk; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors